Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy
Journal for ImmunoTherapy of Cancer · 2024-07 · 12 (7) · e008441
DOI: 10.1136/jitc-2023-008441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 31.07.2024. Verfasst von Motoki Nakamura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan m…. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase, Immunotherapy, Immunogenic Cell Death. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hori Sciences and Arts Foundation, Japanese Association of Geriatric Dermatology Research, Maruho Takagi Dermatology Foundation.
Abstract (Originalsprache)
Background
Enhanced glucose metabolism has been reported in many cancers. Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme involved in the pentose phosphate pathway, which maintains NADPH levels and protects cells from oxidative damage. We recently found that low G6PD expression correlates with active tumor immunity. However, the mechanism involving G6PD and tumor immunity remained unclear.
Methods
We conducted in vitro studies using G6PD-knocked down malignant melanoma cells, pathway analysis using the GEO dataset, in vivo studies in combination with immune checkpoint inhibitors (ICIs) using a mouse melanoma model, and prognostic analysis in 42 melanoma patients and 30 lung cancer patients who were treated with ICIs.
Results
Inhibition of G6PD, both chemically and genetically, has been shown to decrease the production of NADPH and reduce their oxidative stress tolerance. This leads to cell death, which is accompanied by the release of high mobility group box 1 and the translocation of calreticulin to the plasma membrane. These findings suggested that inhibiting G6PD can induce immunogenic cell death. In experiments with C57BL/6 mice transplanted with G6PD-knockdown B16 melanoma cells and treated with anti-PD-L1 antibody, a significant reduction in tumor size was observed. Interestingly, inhibiting G6PD in only a part of the lesions increased the sensitivity of other lesions to ICI. Additionally, out of 42 melanoma patients and 30 lung cancer patients treated with ICIs, those with low G6PD expression had a better prognosis than those with high G6PD expression (p=0.0473; melanoma, p=0.0287; lung cancer).
Conclusion
G6PD inhibition is a potent therapeutic strategy that triggers immunogenic cell death in tumors, significantly augmenting the efficacy of immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan motoki1@med.nagoya-cu.ac.jp.
- Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan.
- Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
ORCID-Profile: Motoki Nakamura
Förderung
- Hori Sciences and Arts Foundation
- Japanese Association of Geriatric Dermatology Research
- Maruho Takagi Dermatology Foundation
Zitieren
APA
Nakamura, M., Magara, T., Yoshimitsu, M., Kano, S., Kato, H., Yokota, K., Okuda, K., & Morita, A. (2024). Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy. Journal for ImmunoTherapy of Cancer, 12(7), e008441. https://doi.org/10.1136/jitc-2023-008441
Vancouver
Nakamura M, Magara T, Yoshimitsu M, Kano S, Kato H, Yokota K, et al. Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy. Journal for ImmunoTherapy of Cancer. 2024;12(7):e008441. doi:10.1136/jitc-2023-008441
BibTeX
@article{Nakamura2024,
author = {Nakamura, Motoki and Magara, Tetsuya and Yoshimitsu, Maki and Kano, Shinji and Kato, Hiroshi and Yokota, Keisuke and Okuda, Katsuhiro and Morita, Akimichi},
title = {Blockade of glucose-6-phosphate dehydrogenase induces immunogenic cell death and accelerates immunotherapy},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
volume = {12},
number = {7},
pages = {e008441},
doi = {10.1136/jitc-2023-008441}
}
EUVIMED